Markets:

Overview

News

Currencies

International

Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

32.74 -1.51 (-4.41%)

Streaming Delayed Price Updated: 1:13 PM EDT, Mar 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Viking Therapeutics, Inc. - Common Stock

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

31 32 Next >

S&P 500, Nasdaq 100 Dip, Small Caps Surge; Bitcoin Tops $57,000, 2 Biotech Stocks Skyrocket: What's Driving Markets Tuesday? ↗

February 27, 2024

On Tuesday, large-cap indices experienced a downturn, while small caps surged, reflecting investor attention on stock valuations.

Via Benzinga

Topics Stocks

Why Is Ligand Pharmaceuticals Stock Trading Higher Today? ↗

February 27, 2024

Ligand Pharmaceuticals beats Q4 2023 sales estimates at $28.1 million, with strong core Captisol and royalty figures. CEO Todd Davis highlights transformative 2023 and optimistic guidance for 2024.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 27, 2024

Via Benzinga

Crude Oil Gains 1%; Macy's Plans To Close 150 Stores ↗

February 27, 2024

U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 150 points on Tuesday. The Dow traded down 0.39% to 38,915.65 while the NASDAQ rose 0.15% to 15,999.50. The S&P...

Via Benzinga

Topics Stocks

(VKTX) - Analyzing Viking Therapeutics's Short Interest ↗

February 20, 2024

Via Benzinga

Recap: Viking Therapeutics Q4 Earnings ↗

February 07, 2024

Via Benzinga

Earnings Scheduled For February 7, 2024 ↗

February 07, 2024

Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million.

Via Benzinga

Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 27, 2024

Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.

Via Benzinga

3 Biotech Stocks Bound to Blast Off By 2029 ↗

February 27, 2024

Biotech stocks are risky, but rewarding. These three biotechs specifically could see exponential gains in the coming years.

Via InvestorPlace

Anheuser-Busch Strike: 5 Things to Know as Brewers Gear Up for Walkout ↗

February 27, 2024

An Anheuser-Busch strike is brewing as the beer company continues troubled negotiations with members of the Teamsters union.

Via InvestorPlace

Earnings Preview: Viking Therapeutics ↗

February 06, 2024

Via Benzinga

Norwegian Cruise Line Posts Strong Sales, Joins Hims & Hers Health, Sterling Infrastructure And Other Big Stocks Moving Higher On Tuesday ↗

February 27, 2024

U.S. stocks were mixed, with the Dow Jones index falling around 100 points on Tuesday.

Via Benzinga

Topics Stocks

Viking Therapeutics Inc. (NASDAQ: VKTX) Near Top of Volume Charts in Tuesday Trading

February 27, 2024

Via Investor Brand Network

Weight Loss Drug Market Gets Crowded As Viking Therapeutics Drops Encouraging Phase 2 Data From Obesity Study ↗

February 27, 2024

Viking Therapeutics' VK2735, a dual GLP-1 and GIP receptor agonist, achieved significant weight loss (up to 14.7%) in metabolic disorder patients. Safe, well-tolerated treatment with no observed...

Via Benzinga

Nasdaq Rises 50 Points; Lowe's Earnings Top Views ↗

February 27, 2024

U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining around 50 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.07% to 39,043.13 while the NASDAQ rose...

Via Benzinga

Topics Stocks

Why Is Viking Therapeutics (VKTX) Stock Up 96% Today? ↗

February 27, 2024

Viking Therapeutics stock is up on Tuesday with heavy trading of VKTX shares after the company reported positive Phase 2 trial results!

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 27, 2024

Via Benzinga

Viking Therapeutics Skyrockets On Weight-Loss Drug Trial Results ↗

February 27, 2024

Eli Lilly and Novo Nordisk fell modestly.

Via Investor's Business Daily

Biotech Stocks Madrigal, Altimmune In A Tizzy As New Weight-Loss Rival Enters The Arena ↗

February 26, 2024

The results from Boehringer Ingelheim and Zealand Pharma bolstered some biotech stocks. But not all got the same boost.

Via Investor's Business Daily

3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024 ↗

February 22, 2024

With new innovation and high demand, biotech stocks could offer some of the most explosive opportunities of the year.

Via InvestorPlace

10 Health Care Stocks Whale Activity In Today's Session ↗

February 19, 2024

Via Benzinga

The 3 Biotech Stocks That Could Make Your February Unforgettable ↗

February 15, 2024

After a blistering hot year of biotech M&A, we’ll see more of the same in 2024. That could be great news for these hot biotech stocks.

Via InvestorPlace

7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution ↗

February 14, 2024

Obesity drug sales boomed in 2023 and will continue in 2024. That could make these weight loss stocks even more attractive.

Via InvestorPlace

Amazon, Progress Software And 2 Other Stocks Insiders Are Selling ↗

February 12, 2024

The Nasdaq 100 closed higher by 1% on Friday. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

The 3 Most Undervalued Biotech Stocks to Buy in February 2024 ↗

February 08, 2024

With patience, some of the most undervalued biotech stocks can create massive wealth, such as these three to consider.

Via InvestorPlace

Why Compass Minerals International Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

February 08, 2024

Shares of Compass Minerals International, Inc. (NYSE: CMP) fell sharply during Thursday’s session following downbeat results.

Via Benzinga

Viking Therapeutics Charges To A Record High On An Update For Its Eli Lilly-Rivaling Obesity Drug ↗

February 08, 2024

The company is looking to take on Eli Lilly's tirzepatide as both a shot and a pill for weight loss.

Via Investor's Business Daily

Arm Holdings Posts Upbeat Results, Joins Hershey, CyberArk Software, Wynn Resorts And Other Big Stocks Moving Higher On Thursday ↗

February 08, 2024

U.S. stocks traded mixed, with the Dow Jones gaining around 20 points on Thursday.

Via Benzinga

Topics Stocks

The 3 Best Biotech Stocks to Invest in for Big Gains in 2024 ↗

February 02, 2024

These pivotal biotech stocks for gains are charting the future of medicine and investment growth in 2024 offering powerful returns

Via InvestorPlace

2 Rising Biotechs That Could Become the Next Novo Nordisk ↗

January 29, 2024

Each of these companies has a big market in its sights.

Via The Motley Fool

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

31 32 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Subscribe
Contact Us
About Press Telegram
Marketplace
Advertising Solutions
Reader Rewards
Subscribe Now

Terms of Use
Cookie Policy
Cookie Preferences
California Notice at Collection
Notice of Financial Incentive
Do Not Sell/Share My Personal Information
Arbitration
Powered by WordPress.com VIP

Copyright 2026 Press Telegram. All rights reserved. The use of any content on this website for the purpose of training artificial intelligence systems, algorithms, machine learning models, text and data mining, or similar use is strictly prohibited without explicit written consent.